1-Benzylimidazole CAS:4238-71-5
1-Benzylimidazole finds extensive applications in different domains, mainly due to its versatile chemical properties. One of its primary uses is in the pharmaceutical industry, where it serves as a key building block for synthesizing biologically active compounds. The presence of the imidazole ring often enhances the pharmacological profile of drugs, making them more effective in targeting specific biological pathways. Researchers have explored its derivatives for potential activity against various diseases, particularly in developing anti-cancer and anti-inflammatory agents. In addition to pharmaceuticals, 1-benzylimidazole is also valuable in the field of material science. Its structural characteristics allow it to participate in polymerization processes, contributing to the development of new materials with desirable physical properties. For example, it can be used in the synthesis of polymers that exhibit improved thermal stability or mechanical strength. Moreover, 1-benzylimidazole acts as a ligand in coordination chemistry, forming complexes with metal ions. These complexes are utilized as catalysts in various organic reactions, improving reaction rates and selectivity. The ability to modulate electronic properties through substitution makes 1-benzylimidazole a promising candidate in the design of catalyst systems for fine chemical synthesis. Furthermore, this compound is employed in laboratory settings as a reagent in various organic transformations. Its utility in acylation, alkylation, and coupling reactions underscores its importance in synthetic methodologies, allowing chemists to construct complex molecules with ease. Overall, 1-benzylimidazole's broad range of applications highlights its significance in advancing research and development across multiple scientific disciplines.
Composition | C9H9N2 |
Assay | 99% |
Appearance | white powder |
CAS No. | 4238-71-5 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |